发明名称 |
Halogenated sulfonamide derivatives |
摘要 |
This invention is directed to halogenated sulfonamide derivatives which are ligands at the NPY Y5 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression which comprises administering to the subject an amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from anxiety which comprises administering to the subject an amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject an amount of a compound of the subject invention. Furthermore, the present invention is directed to use of a compound of the invention for the manufacture of a medicament for treating a subject suffering from depression, anxiety or obesity.
|
申请公布号 |
US2007213376(A1) |
申请公布日期 |
2007.09.13 |
申请号 |
US20070714008 |
申请日期 |
2007.03.05 |
申请人 |
JUBIAN VREJ;PACKIARAJAN MATHIVANAN;REINHARD EMILY |
发明人 |
JUBIAN VREJ;PACKIARAJAN MATHIVANAN;REINHARD EMILY |
分类号 |
A61K31/44 |
主分类号 |
A61K31/44 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|